| Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance DF McGinnity, MG Soars, RA Urbanowicz, RJ Riley Drug metabolism and disposition 32 (11), 1247-1253, 2004 | 369 | 2004 |
| Human adaptation of Ebola virus during the West African outbreak RA Urbanowicz, CP McClure, A Sakuntabhai, AA Sall, G Kobinger, ... Cell 167 (4), 1079-1087. e5, 2016 | 225 | 2016 |
| Quantitative validation and comparison of multiplex cytokine kits JL Richens, RA Urbanowicz, R Metcalf, J Corne, P O’Shea, L Fairclough Journal of biomolecular screening 15 (5), 562-568, 2010 | 122 | 2010 |
| Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients RA Urbanowicz, JR Lamb, I Todd, JM Corne, LC Fairclough Respiratory research 11, 1-9, 2010 | 109 | 2010 |
| Hepatitis C virus vaccine: challenges and prospects JD Duncan, RA Urbanowicz, AW Tarr, JK Ball Vaccines 8 (1), 90, 2020 | 99 | 2020 |
| The role of neutralizing antibodies in hepatitis C virus infection VC Edwards, AW Tarr, RA Urbanowicz, JK Ball Journal of General Virology 93 (1), 1-19, 2012 | 91 | 2012 |
| An alpaca nanobody inhibits hepatitis C virus entry and cell‐to‐cell transmission AW Tarr, P Lafaye, L Meredith, L Damier‐Piolle, RA Urbanowicz, A Meola, ... Hepatology 58 (3), 932-939, 2013 | 86 | 2013 |
| Altered effector function of peripheral cytotoxic cells in COPD RA Urbanowicz, JR Lamb, I Todd, JM Corne, LC Fairclough Respiratory research 10, 1-13, 2009 | 86 | 2009 |
| Killer cells in chronic obstructive pulmonary disease L Fairclough, RA Urbanowicz, J Corne, JR Lamb Clinical science 114 (8), 533-541, 2008 | 80 | 2008 |
| A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance RA Urbanowicz, CP McClure, RJP Brown, T Tsoleridis, MAA Persson, ... Journal of virology 90 (7), 3288-3301, 2016 | 77 | 2016 |
| Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization AW Tarr, RA Urbanowicz, D Jayaraj, RJP Brown, JA McKeating, WL Irving, ... Journal of virology 86 (5), 2739-2749, 2012 | 74 | 2012 |
| Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD) J Wang, RA Urbanowicz, PJ Tighe, I Todd, JM Corne, LC Fairclough PloS one 8 (3), e58556, 2013 | 73 | 2013 |
| The role of humoral innate immunity in hepatitis C virus infection AW Tarr, RA Urbanowicz, JK Ball Viruses 4 (1), 1-27, 2012 | 71 | 2012 |
| Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not … AW Tarr, RA Urbanowicz, MR Hamed, A Albecka, CP McClure, ... Journal of virology 85 (9), 4246-4257, 2011 | 71 | 2011 |
| Antigenicity and immunogenicity of differentially glycosylated hepatitis C virus E2 envelope proteins expressed in mammalian and insect cells RA Urbanowicz, R Wang, JE Schiel, Z Keck, MC Kerzic, P Lau, ... Journal of virology 93 (7), 10.1128/jvi. 01403-18, 2019 | 65 | 2019 |
| Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19 S Capone, A Raggioli, M Gentile, S Battella, A Lahm, A Sommella, ... Molecular Therapy 29 (8), 2412-2423, 2021 | 60 | 2021 |
| Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection RA Urbanowicz, T Tsoleridis, HJ Jackson, L Cusin, JD Duncan, ... Science translational medicine 13 (609), eabj0847, 2021 | 54* | 2021 |
| An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule E Nigro, I Colavita, D Sarnataro, O Scudiero, G Zambrano, V Granata, ... Scientific reports 5 (1), 18450, 2015 | 50 | 2015 |
| Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay RA Urbanowicz, CP McClure, B King, CP Mason, JK Ball, AW Tarr Journal of General Virology 97 (9), 2265-2279, 2016 | 46 | 2016 |
| Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy? Y Abo-Zeid, RA Urbanowicz, BJ Thomson, WL Irving, AW Tarr, ... International journal of pharmaceutics 547 (1-2), 572-581, 2018 | 38 | 2018 |
Jonathan BallLSTM and University of NottinghamPatvirtintas el. paštas LSTMed.ac.uk
